Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.20 | 0.86% | 259.40 | 260.00 | 260.40 | 260.60 | 257.60 | 259.00 | 5,634,622 | 16:35:25 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | 2.29B | 190.5M | 0.0929 | 28.03 | 5.27B |
From Apr 2023 to Apr 2025
Convatec Group PLC (CTEC) Convatec Group PLC: Total Voting Rights 31-May-2023 / 10:06 GMT/BST
-----------------------------------------------------------------------------------------------------------------------
31 May 2023
Convatec Group Plc ("Convatec" or "the Company")
Total Voting Rights
The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 May 2023, the Company's issued capital with voting rights consisted of 2,045,589,597 ordinary shares of 10p each ("Shares"). The Company does not hold any Shares in Treasury at the date of this disclosure.
The above figure (2,045,589,597) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to, their interest in the Company under the UK Financial Conduct Authority's Disclosure and Transparency Rules.
Enquiries
Grace McCalla, Assistant Company Secretary +44(0)7575353388
Cosec@convatec.com
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over USD2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com.
----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD3VFW73 Category Code: TVR TIDM: CTEC LEI Code: 213800LS272L4FIDOH92 Sequence No.: 247622 EQS News ID: 1645963 End of Announcement EQS News Service =------------------------------------------------------------------------------------
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1645963&application_name=news
(END) Dow Jones Newswires
May 31, 2023 05:06 ET (09:06 GMT)
1 Year Convatec Chart |
1 Month Convatec Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
